Cover ImageSALE
市場調查報告書

表觀遺傳學的全球市場:2017年∼2021年

Global Epigenetics Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 544311
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
表觀遺傳學的全球市場:2017年∼2021年 Global Epigenetics Market 2017-2021
出版日期: 2017年08月14日 內容資訊: 英文 78 Pages
簡介

全球表觀遺傳學市場在2017年到2021年間,預測將以13.22%的年複合成長率 (CAGR) 擴大。

本報告依產品及地區別提供全球表觀遺傳學市場現狀分析與今後預測,再加上市場成長因素與課題,主要趨勢,主要企業簡介等資訊。

第1章 摘要整理

第2章 本報告的調查範圍

第3章 調查手法

第4章 簡介

  • 市場概要

第5章 市場形勢

  • 市場規模與預測
  • 波特的五力分析

第6章 各產品的市場分類

  • 全球表觀遺傳學市場:各產品
  • 試劑
  • 套件
  • 其他

第7章 地理區分

  • 全球表觀遺傳學市場:各地區
  • 南北美洲
  • 歐洲·中東·非洲地區
  • 亞太地區

第8章 決策架構

第9章 市場成長因素與課題

  • 市場成長因素
  • 市場課題

第10章 市場趨勢

第11章 業者情勢

  • 競爭模式
  • 投資機會分析

第12章 主要供應商分析

  • Abcam
  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher Scientific
  • 其他卓越供應商

第13章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR14266

About Epigenetics

Epigenetics is a biological process to control gene expression by altering the chromatin structure. Genes which are going to be expressed are associated with accessible chromatin regions, whereas silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic changes on the basis of which epigenetic therapy develops.

Technavio's analysts forecast the global epigenetics market to grow at a CAGR of 13.22% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global epigenetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of epigenetics products.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Epigenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abcam
  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Active Motif
  • BellBrook Labs
  • BioVision
  • CELGENE
  • Cisbio.com
  • Diagenode
  • Epizyme
  • Illumina
  • New England Biolabs
  • Novartis
  • QIAGEN

Market driver

  • Increasing prevalence of cancer
  • For a full, detailed list, view our report

Market challenge

  • Difficulty in finding predictive epigenetic biomarker
  • For a full, detailed list, view our report

Market trend

  • Increasing demand for personalized medicine
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global epigenetics market by product
  • Global epigenetics market by reagents
  • Global epigenetics market by kits
  • Global epigenetics market by others

PART 07: Geographical segmentation

  • Global epigenetics market by geography
  • Epigenetics market in Americas
  • Epigenetics market in EMEA
  • Epigenetics market in APAC

PART 08: Decision framework

PART 09: Drivers and challenges

  • Market drivers
  • Market challenges

PART 10: Market trends

  • Increasing use of epigenetics as a tool to understand development and disease
  • Increasing demand for personalized medicine
  • Rise in investment in R&D

PART 11: Vendor landscape

  • Competitive scenario
  • Investment opportunity analysis

PART 12: Key vendor analysis

  • Abcam
  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 13: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Epigenetic changes in DNA
  • Exhibit 02: Normal cellular functions regulated by epigenetic mechanisms and molecular abnormalities caused by epigenetic errors
  • Exhibit 03: Global epigenetics market: Market overview
  • Exhibit 04: Global epigenetics market 2016-2021 ($ billions)
  • Exhibit 05: Factors impacting global epigenetics market
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global epigenetics market by product 2016-2021 (% share)
  • Exhibit 08: Global epigenetics market by product: Snapshot
  • Exhibit 09: Global epigenetics market by reagents 2016-2021 ($ billions)
  • Exhibit 10: Global epigenetic market by kits 2016-2021 ($ billions)
  • Exhibit 11: Global epigenetic market by others 2016-2021 ($ billions)
  • Exhibit 12: Global epigenetics market by geography 2016-2021 (% share)
  • Exhibit 13: Global epigenetics market by geography: Snapshot
  • Exhibit 14: Epigenetics market in Americas 2016-2021 ($ billions)
  • Exhibit 15: Epigenetics market in EMEA 2016-2021 ($ billions)
  • Exhibit 16: Epigenetics market in APAC 2016-2021 ($ billions)
  • Exhibit 17: Competitive parameters in global epigenetics market
  • Exhibit 18: Investment opportunity mapping
  • Exhibit 19: Strategic success factors for companies
  • Exhibit 20: Abcam: Company profile
  • Exhibit 21: Abcam: Strength analysis
  • Exhibit 22: Abcam: Strategy assessment
  • Exhibit 23: Abcam: Opportunity assessment
  • Exhibit 24: Bio-Rad Laboratories: Company profile
  • Exhibit 25: Bio-Rad Laboratories: Strength analysis
  • Exhibit 26: Bio-Rad Laboratories: Strategy assessment
  • Exhibit 27: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 28: Merck: Company profile
  • Exhibit 29: Merck: Strength analysis
  • Exhibit 30: Merck: Strategy assessment
  • Exhibit 31: Merck: Opportunity assessment
  • Exhibit 32: Thermo Fisher Scientific: Company profile
  • Exhibit 33: Thermo Fisher Scientific: Strength analysis
  • Exhibit 34: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 35: Thermo Fisher Scientific: Opportunity assessment
Back to Top